Atrium Therapeutics, Inc.
NASDAQ:RNABiotechnology
+$0.16 today
- Market cap
- $143.23M
- Beta
- 0.42
- P/E (TTM)
- -3.3
- EPS (TTM)
- -$3.78
Volume 0.22M
Average 0.35M
RNA Purchases of Investments
Cash used to buy marketable securities and other investments.
Atrium Therapeutics, Inc.NASDAQ: RNA
Purchases of Investments · Q1 FY2026 · quarter ended Mar 2026
Purchases of investments of $0 in Q1 FY2026
Q1 FY2026 purchases of investments was $0.
Context
- Purchases of investments amounted to 0.0% of revenue in FY2025.
Sources:Cash FlowText generated from reported figures; not investment advice.
Purchases of Investments history
USD · from the cash flow
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Purchases of Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
Purchases of Investments vs competitors
How RNA compares with its peers on the latest reported figures
No competitor Purchases of Investments figures are available to compare.
Cash Flow Statement
Atrium Therapeutics, Inc.
NASDAQ:RNA
Intrinsic Alpha fair value
Locked
Current Price
$6.64
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.